20 years helping business leaders deliver alpha. View our success stories
20 years helping business leaders deliver alpha. View our success stories
By Humatica
Humatica Ltd. was retained to advise the Riverside Company on its investment in Alter Pharma, a Belgian pharmaceutical group. Alter Pharma distributes EU-sourced pharmaceutical products to wholesalers pharmacies and hospitals. It also develops and reformulates generic pharmaceuticals using GMP approved third-party manufacturers, and sells them internationally through partnerships
Humatica provided organisational due diligence services for this transaction.
To view press release: Humatica Advisor to Riverside for AlterPharma
2024 was a milestone year for private equity, and for Humatica. The industry is under greater pressure to generate acceptable returns than ever before. With…
Read more
We are pleased to announce Humatica’s expansion in the United States following a long history of successful project delivery there from Europe. This marks a…
Read more
Humatica’s Andros Payne provided expert insights into leveraging organizational effectiveness for value creation at this year’s Private Equity Insights DACH Conference in Munich. Leaders play…
Read more
